Lista de obras -

A conceptual disease model for adult Pompe disease

artículo científico publicado en 2015

A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.

artículo científico publicado en 2018

Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?

scientific article published on 14 May 2015

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

artículo científico publicado en 2017

Assessing Costs Using the Treatment Inventory Cost in Psychiatric Patients (TIC-P), TIC-P Mini and TIC-P Midi

scientific article published on 01 March 2019

Burden of illness of Pompe disease in patients only receiving supportive care.

artículo científico publicado en 2011

Care-related Quality of Life of informal caregivers of the elderly after a hip fracture

artículo científico publicado en 2017

Comparison of EQ-5D and SF-6D utilities in Pompe disease.

artículo científico publicado en 2014

Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room

artículo científico publicado en 2015

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease

artículo científico publicado en 2017

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

artículo científico publicado en 2014

Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria

scientific article published on 15 June 2018

Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study.

artículo científico publicado en 2018

Orphan drugs expenditure in the Netherlands in the period 2006-2012.

artículo científico publicado en 2014

Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands

scientific article published on 01 September 2018

Systematic review of available evidence on 11 high-priced inpatient orphan drugs.

artículo científico publicado en 2013

The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument.

artículo científico publicado en 2013

Update of the Dutch manual for costing studies in health care

artículo científico publicado en 2017

Lista de obras de

A conceptual disease model for adult Pompe disease

A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.

Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug?

Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

Assessing Costs Using the Treatment Inventory Cost in Psychiatric Patients (TIC-P), TIC-P Mini and TIC-P Midi

Burden of illness of Pompe disease in patients only receiving supportive care.

Care-related Quality of Life of informal caregivers of the elderly after a hip fracture

Comparison of EQ-5D and SF-6D utilities in Pompe disease.

Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catheterization laboratory vs. Reveal LINQ in a procedure room

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria

Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study.

Orphan drugs expenditure in the Netherlands in the period 2006-2012.

Potential cost savings owing to the route of administration of oncology drugs: a microcosting study of intravenous and subcutaneous administration of trastuzumab and rituximab in the Netherlands

Systematic review of available evidence on 11 high-priced inpatient orphan drugs.

The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument.

Update of the Dutch manual for costing studies in health care